Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02574468Phase 4Completed
Phase 4, randomised, double-blind trial of dexamethasone (4 arms). Primary endpoints: Histologic Evaluation of pulp for inflammation at 60 days, Histologic Evaluation of pulp for calcified bridge at 60 days and 1 more. Started Jan 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02574468.